Literature DB >> 4561532

Immune therapy of malignant melanoma.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4561532      PMCID: PMC1940788     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Immunological effects of BCG in malignant melanoma: two modes of administration compared.

Authors:  A Z Bluming; C L Vogel; J L Ziegler; N Mody; G Kamya
Journal:  Ann Intern Med       Date:  1972-03       Impact factor: 25.391

2.  Intralymphatic therapy with immune lymphocytes.

Authors:  C J McPeak
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

3.  Clinical experiences in immunotherapy of cancer.

Authors:  E T Krementz; M S Samuels; J H Wallace; E N Benes
Journal:  Surg Gynecol Obstet       Date:  1971-08

4.  Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

Authors:  D L Morton; F R Eilber; W L Joseph; W C Wood; E Trahan; A S Ketcham
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

5.  Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.

Authors:  G A Currie; F Lejeune; G H Fairley
Journal:  Br Med J       Date:  1971-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.